Consistent with these observations, NOS inhibitor L‐NAME treatment lowered NO concentrations and completely blocked the beneficial effects of DMY on atherosclerotic lesion formation in Apoe−/− mice and endothelial function (Figure 1), suggesting DMY improves endothelial function and attenuates atherosclerosis in a NO‐dependent manner. This evidence concerns the gene APOE and atherosclerosis.